30283031|t|Integrative approach to sporadic Alzheimer's disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau.
30283031|a|TYROBP/DAP12 forms complexes with ectodomains of immune receptors (TREM2, SIRPbeta1, CR3) associated with Alzheimer's disease (AD) and is a network hub and driver in the complement subnetwork identified by multi-scale gene network studies of postmortem human AD brain. Using transgenic or viral approaches, we characterized in mice the effects of TYROBP deficiency on the phenotypic and pathological evolution of tauopathy. Biomarkers usually associated with worsening clinical phenotype (i.e., hyperphosphorylation and increased tauopathy spreading) were unexpectedly increased in MAPTP301S;Tyrobp-/- mice despite the improved learning behavior and synaptic function relative to controls with normal levels of TYROBP. Notably, levels of complement cascade initiator C1q were reduced in MAPTP301S;Tyrobp-/- mice, consistent with the prediction that C1q reduction exerts a neuroprotective effect. These observations suggest a model wherein TYROBP-KO-(knock-out)-associated reduction in C1q is associated with normalized learning behavior and electrophysiological properties in tauopathy model mice despite a paradoxical evolution of biomarker signatures usually associated with neurological decline.
30283031	33	52	Alzheimer's disease	Disease	MESH:D000544
30283031	68	74	TYROBP	Gene	22177
30283031	80	89	tauopathy	Disease	MESH:D024801
30283031	90	95	mouse	Species	10090
30283031	110	113	C1q	Gene	12259
30283031	209	215	TYROBP	Gene	22177
30283031	216	221	DAP12	Gene	22177
30283031	276	281	TREM2	Gene	54209
30283031	283	292	SIRPbeta1	Gene	10326
30283031	294	297	CR3	Gene	6998
30283031	315	334	Alzheimer's disease	Disease	MESH:D000544
30283031	336	338	AD	Disease	MESH:D000544
30283031	462	467	human	Species	9606
30283031	468	470	AD	Disease	MESH:D000544
30283031	536	540	mice	Species	10090
30283031	556	562	TYROBP	Gene	22177
30283031	622	631	tauopathy	Disease	MESH:D024801
30283031	739	748	tauopathy	Disease	MESH:D024801
30283031	791	800	MAPTP301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
30283031	800	807	;Tyrobp	Gene	22177
30283031	811	815	mice	Species	10090
30283031	920	926	TYROBP	Gene	22177
30283031	976	979	C1q	Gene	12259
30283031	996	1005	MAPTP301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
30283031	1005	1012	;Tyrobp	Gene	22177
30283031	1016	1020	mice	Species	10090
30283031	1058	1061	C1q	Gene	12259
30283031	1148	1154	TYROBP	Gene	22177
30283031	1194	1197	C1q	Gene	12259
30283031	1285	1294	tauopathy	Disease	MESH:D024801
30283031	1301	1305	mice	Species	10090
30283031	1386	1406	neurological decline	Disease	MESH:D009461
30283031	Association	MESH:D024801	RS#:63751438;HGVS:p.P301S;CorrespondingGene:4137
30283031	Association	MESH:D024801	22177
30283031	Association	MESH:D000544	22177
30283031	Association	MESH:D000544	54209
30283031	Association	MESH:D000544	10326
30283031	Association	22177	54209
30283031	Association	MESH:D024801	12259
30283031	Positive_Correlation	12259	22177
30283031	Association	10326	22177
30283031	Association	22177	6998
30283031	Association	MESH:D009461	22177
30283031	Association	MESH:D024801	4137

